Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 31 | 2020 | 951 | 2.450 |
Why?
|
| Magnetic Resonance Imaging | 33 | 2020 | 1328 | 1.690 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2017 | 226 | 1.010 |
Why?
|
| Auditory Perception | 7 | 2009 | 80 | 0.840 |
Why?
|
| Appetite | 2 | 2020 | 22 | 0.840 |
Why?
|
| Obesity | 7 | 2020 | 1175 | 0.830 |
Why?
|
| Brain Mapping | 16 | 2018 | 178 | 0.800 |
Why?
|
| Somatosensory Cortex | 2 | 2017 | 26 | 0.800 |
Why?
|
| Nerve Net | 9 | 2018 | 123 | 0.730 |
Why?
|
| Exercise | 5 | 2018 | 672 | 0.640 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 80 | 0.630 |
Why?
|
| Beta vulgaris | 2 | 2017 | 11 | 0.630 |
Why?
|
| Cerebral Infarction | 4 | 2008 | 22 | 0.630 |
Why?
|
| Visual Perception | 6 | 2009 | 116 | 0.580 |
Why?
|
| Visual Cortex | 6 | 2009 | 35 | 0.520 |
Why?
|
| Cerebrovascular Circulation | 9 | 2011 | 93 | 0.500 |
Why?
|
| Humans | 62 | 2020 | 32005 | 0.470 |
Why?
|
| Weight Loss | 4 | 2018 | 480 | 0.450 |
Why?
|
| Auditory Cortex | 4 | 2009 | 21 | 0.450 |
Why?
|
| Male | 40 | 2020 | 19165 | 0.420 |
Why?
|
| Cerebral Cortex | 5 | 2009 | 126 | 0.400 |
Why?
|
| Female | 38 | 2020 | 19959 | 0.400 |
Why?
|
| Aged | 25 | 2020 | 10301 | 0.390 |
Why?
|
| Adult | 34 | 2018 | 9345 | 0.370 |
Why?
|
| Aging | 6 | 2015 | 946 | 0.360 |
Why?
|
| Music | 2 | 2007 | 8 | 0.340 |
Why?
|
| Career Mobility | 2 | 2019 | 16 | 0.330 |
Why?
|
| Acoustic Stimulation | 12 | 2018 | 126 | 0.330 |
Why?
|
| Prefrontal Cortex | 2 | 2013 | 71 | 0.330 |
Why?
|
| Attention | 3 | 2009 | 83 | 0.320 |
Why?
|
| Radiology | 2 | 2019 | 41 | 0.320 |
Why?
|
| Faculty, Medical | 2 | 2019 | 78 | 0.310 |
Why?
|
| Middle Aged | 27 | 2020 | 11817 | 0.310 |
Why?
|
| Perception | 2 | 2012 | 98 | 0.310 |
Why?
|
| Neural Inhibition | 1 | 2008 | 28 | 0.300 |
Why?
|
| Gyrus Cinguli | 2 | 2008 | 22 | 0.300 |
Why?
|
| Cognition | 4 | 2016 | 555 | 0.300 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2011 | 77 | 0.300 |
Why?
|
| Spin Labels | 5 | 2011 | 24 | 0.290 |
Why?
|
| Auditory Pathways | 2 | 2006 | 10 | 0.280 |
Why?
|
| Dyslexia | 2 | 2005 | 8 | 0.280 |
Why?
|
| Image Enhancement | 3 | 2009 | 72 | 0.280 |
Why?
|
| Tomography, X-Ray | 1 | 2006 | 5 | 0.270 |
Why?
|
| Walking | 2 | 2017 | 209 | 0.250 |
Why?
|
| Overweight | 2 | 2018 | 280 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2018 | 112 | 0.250 |
Why?
|
| Caffeine | 4 | 2009 | 29 | 0.250 |
Why?
|
| Software | 3 | 2015 | 123 | 0.240 |
Why?
|
| Nitrates | 2 | 2017 | 27 | 0.240 |
Why?
|
| Nicotine | 2 | 2017 | 171 | 0.240 |
Why?
|
| Reference Books, Medical | 1 | 2004 | 2 | 0.230 |
Why?
|
| Software Validation | 1 | 2004 | 4 | 0.230 |
Why?
|
| Medical Illustration | 1 | 2004 | 6 | 0.230 |
Why?
|
| Medical Informatics Applications | 1 | 2004 | 8 | 0.230 |
Why?
|
| Pesticides | 2 | 2017 | 199 | 0.230 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 23 | 0.230 |
Why?
|
| Echo-Planar Imaging | 2 | 2009 | 15 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 918 | 0.230 |
Why?
|
| Perfusion | 1 | 2004 | 73 | 0.230 |
Why?
|
| Occupational Exposure | 2 | 2017 | 232 | 0.230 |
Why?
|
| Frontal Lobe | 1 | 2004 | 36 | 0.230 |
Why?
|
| Photic Stimulation | 10 | 2009 | 158 | 0.220 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 109 | 0.210 |
Why?
|
| Reaction Time | 5 | 2006 | 117 | 0.210 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 3990 | 0.210 |
Why?
|
| Internet | 1 | 2004 | 195 | 0.200 |
Why?
|
| Resistance Training | 3 | 2018 | 82 | 0.200 |
Why?
|
| Parietal Lobe | 2 | 2013 | 13 | 0.190 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 127 | 0.190 |
Why?
|
| Neural Pathways | 5 | 2017 | 94 | 0.180 |
Why?
|
| Oxygen | 5 | 2017 | 142 | 0.180 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 12 | 0.180 |
Why?
|
| Reproducibility of Results | 5 | 2009 | 762 | 0.170 |
Why?
|
| Double-Blind Method | 3 | 2017 | 525 | 0.160 |
Why?
|
| Mentors | 1 | 2019 | 31 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.160 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 60 | 0.160 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 47 | 0.150 |
Why?
|
| Body Composition | 2 | 2017 | 397 | 0.150 |
Why?
|
| Dietary Supplements | 2 | 2017 | 185 | 0.150 |
Why?
|
| Pain | 2 | 2011 | 288 | 0.150 |
Why?
|
| Military Personnel | 1 | 2018 | 92 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 132 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2017 | 240 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 2 | 2009 | 52 | 0.140 |
Why?
|
| Quality of Life | 3 | 2017 | 946 | 0.130 |
Why?
|
| Psychomotor Performance | 3 | 2005 | 99 | 0.130 |
Why?
|
| Cerebellum | 2 | 2013 | 26 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 2 | 2009 | 76 | 0.130 |
Why?
|
| Nitrites | 2 | 2017 | 21 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 51 | 0.120 |
Why?
|
| Gambling | 1 | 2014 | 6 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 244 | 0.120 |
Why?
|
| Functional Laterality | 3 | 2011 | 56 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 249 | 0.110 |
Why?
|
| Thalamus | 1 | 2013 | 33 | 0.110 |
Why?
|
| Brain Injuries | 2 | 2011 | 93 | 0.110 |
Why?
|
| Analysis of Variance | 6 | 2011 | 463 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2014 | 87 | 0.110 |
Why?
|
| Hispanic Americans | 2 | 2017 | 940 | 0.110 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 390 | 0.110 |
Why?
|
| Motor Activity | 1 | 2015 | 325 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 125 | 0.110 |
Why?
|
| Mobility Limitation | 1 | 2014 | 219 | 0.100 |
Why?
|
| Social Control, Informal | 1 | 2012 | 8 | 0.100 |
Why?
|
| Decision Making | 1 | 2014 | 195 | 0.100 |
Why?
|
| Food Preferences | 1 | 2012 | 36 | 0.100 |
Why?
|
| Corpus Callosum | 2 | 2020 | 18 | 0.100 |
Why?
|
| Putamen | 1 | 2011 | 25 | 0.100 |
Why?
|
| Holistic Health | 1 | 2011 | 7 | 0.100 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 10 | 0.090 |
Why?
|
| Diet | 2 | 2012 | 391 | 0.090 |
Why?
|
| Comprehension | 1 | 2011 | 19 | 0.090 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2011 | 21 | 0.090 |
Why?
|
| Heart Failure | 1 | 2017 | 639 | 0.090 |
Why?
|
| Pruritus | 1 | 2011 | 47 | 0.090 |
Why?
|
| Young Adult | 6 | 2015 | 2636 | 0.090 |
Why?
|
| Cues | 3 | 2006 | 68 | 0.090 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 371 | 0.090 |
Why?
|
| Hypertension | 1 | 2017 | 959 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 517 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 8 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2009 | 12 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 38 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 22 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2009 | 38 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2014 | 117 | 0.080 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2008 | 8 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2017 | 293 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 18 | 0.080 |
Why?
|
| Models, Biological | 1 | 2010 | 392 | 0.080 |
Why?
|
| Neurologic Examination | 2 | 2011 | 28 | 0.080 |
Why?
|
| Hemiplegia | 1 | 2007 | 13 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2017 | 3509 | 0.070 |
Why?
|
| Arm | 1 | 2007 | 35 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 29 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2011 | 356 | 0.070 |
Why?
|
| Hand | 1 | 2007 | 66 | 0.070 |
Why?
|
| Coffee | 2 | 2003 | 8 | 0.070 |
Why?
|
| Rest | 2 | 2017 | 53 | 0.070 |
Why?
|
| Contrast Media | 2 | 2009 | 138 | 0.070 |
Why?
|
| Cotinine | 2 | 2017 | 49 | 0.070 |
Why?
|
| Time Perception | 1 | 2006 | 8 | 0.070 |
Why?
|
| Judgment | 1 | 2006 | 11 | 0.070 |
Why?
|
| Pitch Discrimination | 1 | 2005 | 1 | 0.070 |
Why?
|
| Diffusion | 2 | 2002 | 13 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 48 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 582 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1128 | 0.060 |
Why?
|
| Single-Blind Method | 3 | 2017 | 203 | 0.060 |
Why?
|
| Internship and Residency | 2 | 2019 | 313 | 0.060 |
Why?
|
| Muscle Strength | 2 | 2017 | 161 | 0.060 |
Why?
|
| Time Factors | 3 | 2006 | 2149 | 0.060 |
Why?
|
| Probability | 2 | 2017 | 158 | 0.060 |
Why?
|
| Blood Volume | 1 | 2004 | 8 | 0.060 |
Why?
|
| Adolescent | 5 | 2011 | 3539 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2003 | 17 | 0.060 |
Why?
|
| Myopia | 1 | 2003 | 5 | 0.060 |
Why?
|
| Sound Localization | 1 | 2003 | 7 | 0.060 |
Why?
|
| Arousal | 1 | 2003 | 19 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2004 | 64 | 0.060 |
Why?
|
| Stroke | 1 | 2009 | 585 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2005 | 898 | 0.050 |
Why?
|
| Brain Edema | 1 | 2003 | 15 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 125 | 0.050 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 26 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2002 | 2 | 0.050 |
Why?
|
| Age Factors | 3 | 2014 | 1188 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 154 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 16 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 10 | 0.050 |
Why?
|
| Hearing | 1 | 2002 | 11 | 0.050 |
Why?
|
| Language | 1 | 2002 | 42 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 313 | 0.050 |
Why?
|
| Acute Disease | 1 | 2002 | 253 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 77 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 638 | 0.040 |
Why?
|
| Pain Threshold | 2 | 2011 | 92 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2019 | 23 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2011 | 350 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2265 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2009 | 108 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 86 | 0.040 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 18 | 0.040 |
Why?
|
| Butyrylcholinesterase | 1 | 2017 | 14 | 0.040 |
Why?
|
| Sensory Thresholds | 2 | 2009 | 28 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2018 | 106 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2017 | 36 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3306 | 0.040 |
Why?
|
| Child | 3 | 2011 | 2438 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1817 | 0.030 |
Why?
|
| Cholinesterases | 1 | 2016 | 10 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 164 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 175 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2016 | 103 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 270 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 137 | 0.030 |
Why?
|
| Information Theory | 1 | 2014 | 3 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2017 | 348 | 0.030 |
Why?
|
| Agriculture | 1 | 2016 | 186 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 408 | 0.030 |
Why?
|
| Behavior | 1 | 2013 | 30 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 28 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 53 | 0.030 |
Why?
|
| Reward | 1 | 2014 | 64 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2016 | 290 | 0.030 |
Why?
|
| Infant | 2 | 2009 | 1061 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 845 | 0.030 |
Why?
|
| Reference Values | 2 | 2003 | 246 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2009 | 1269 | 0.030 |
Why?
|
| Drive | 1 | 2012 | 2 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2012 | 10 | 0.030 |
Why?
|
| Taste | 1 | 2012 | 17 | 0.030 |
Why?
|
| Water | 1 | 2012 | 56 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 32 | 0.020 |
Why?
|
| Bone Density | 1 | 2013 | 205 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 20 | 0.020 |
Why?
|
| Psychoacoustics | 1 | 2011 | 2 | 0.020 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2012 | 78 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2011 | 23 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 128 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 53 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 226 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2011 | 78 | 0.020 |
Why?
|
| Mental Processes | 1 | 2010 | 17 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2012 | 161 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 355 | 0.020 |
Why?
|
| Saliva | 1 | 2009 | 36 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3876 | 0.020 |
Why?
|
| Animals | 2 | 2011 | 7541 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 187 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2009 | 15 | 0.020 |
Why?
|
| Arteries | 1 | 2009 | 67 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2009 | 71 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 633 | 0.020 |
Why?
|
| Motor Skills | 1 | 2007 | 13 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2009 | 146 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 51 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 495 | 0.020 |
Why?
|
| Fingers | 1 | 2007 | 64 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 218 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 181 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2006 | 32 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2007 | 199 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 55 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 411 | 0.010 |
Why?
|
| Cerebral Ventriculography | 1 | 2003 | 3 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 5 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 17 | 0.010 |
Why?
|
| Fixation, Ocular | 1 | 2002 | 5 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 447 | 0.010 |
Why?
|
| Acetazolamide | 1 | 2002 | 1 | 0.010 |
Why?
|
| Anisotropy | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 161 | 0.010 |
Why?
|